Sangeeta Lakhi 
Dealstreet

Rajani Associates advises Sudarshan Pharma on $20 Million FCCB issue

Sudarshan Pharma is engaged in the pharmaceutical business and is known for manufacturing and trading, inter alia, specialty chemicals, agro chemicals, and paints.

Bar & Bench

Sudarshan Pharma Industries Limited has raised $20 million by way of a Foreign Currency Convertible Bonds (FCCB) issue.

Rajani Associates advised Sudarshan Pharma on this FCCB issue.

The transaction was led by Sangeeta Lakhi (Senior Partner), with support from Associates Sommya Khandelwal, Dipendra Singh Tomar and Rishi Sharma.

Sudarshan Pharma

Sudarshan Pharma is engaged in the pharmaceutical business and is known for manufacturing and trading, inter alia, specialty chemicals, agro chemicals, and paints. The Company also provides customized specialty chemicals to customers in India and overseas.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Will menstrual hygiene judgment remain on paper? Supreme Court seeks implementation details

Supreme Court seeks Centre's response to plea seeking ban on social media for children

Supreme Court issues contempt notice to Sanjay Raut, Nikhil Wagle over remarks targeting CJI Kant, judiciary

Is uncapped ad valorem court fee a form of tax? Supreme Court to examine

Journalist moves Supreme Court alleging Rahul Gandhi pushed her during October 12 march

SCROLL FOR NEXT